Publications by authors named "Fabio Baschiera"

Claim this Profile
N
Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator Runcaciguat in Diabetic and Ischemic Retinopathy.
Elia J Duh, Zhenhua Xu, Hongkwan Cho, Shirley Wu, William Schubert, Fabio Baschiera

Diabetes· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the 2023 Mary Tyler Moore Vision Initiative Workshop.
S Robert Levine, Dorene S Markel, Martin G Myers, Ryan Barunas, Jennifer K Sun, Fabio Baschiera

Transl Vis Sci Technol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of exercise on central aortic pressure before and after treatment with renin-angiotensin system blockade in patients with hypertension.
Peter S Lacy, Patrick Brunel, Fabio Baschiera, Jaco Botha, Bryan Williams

J Renin Angiotensin Aldosterone Syst· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of treatment withdrawal on brachial and central aortic pressure after direct renin inhibition or angiotensin receptor blockade.
Peter S Lacy, Patrick Brunel, Giovanni Bader, Alexander Jones, Fabio Baschiera

J Renin Angiotensin Aldosterone Syst· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS.
Fabio Baschiera, William Chang, Patrick Brunel,

Vasc Health Risk Manag· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.
Mihai Gheorghiade, Muthiah Vaduganathan, Stephen J Greene, Robert J Mentz, Kirkwood F Adams, Fabio Baschiera

Heart Fail Rev· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Aldo P Maggioni, Stephen J Greene, Gregg C Fonarow, Michael Böhm, Faiez Zannad, Fabio Baschiera

Eur Heart J· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel description of the 24-hour circadian rhythms of brachial versus central aortic blood pressure and the impact of blood pressure treatment in a randomized controlled clinical trial: The Ambulatory Central Aortic Pressure (AmCAP) Study.
Bryan Williams, Peter S Lacy, Fabio Baschiera, Patrick Brunel, Rainer Düsing

Hypertension· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise testing in hypertensive patients for assessing the cardiovascular protective potential of antihypertensive drugs.
Patrick Brunel, Fabio Baschiera, Renata Cifkova

Ther Adv Cardiovasc Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and plasma renin activity responses to different strategies to inhibit the renin-angiotensin-aldosterone system during exercise.
Bryan Williams, Fabio Baschiera, Peter S Lacy, Jaco Botha, Margaret F Prescott

J Renin Angiotensin Aldosterone Syst· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Mihai Gheorghiade, Michael Böhm, Stephen J Greene, Gregg C Fonarow, Eldrin F Lewis, Fabio Baschiera

JAMA· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained blood pressure-lowering effect of aliskiren compared with telmisartan after a single missed dose.
Rainer Düsing, Patrick Brunel, InYoung Baek, Fabio Baschiera

J Clin Hypertens (Greenwich)· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).
Henry R Black, Fernando Aguirre P, Melanie Wright, Thomas Alessi, Fabio Baschiera

J Clin Hypertens (Greenwich)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: the ASSERTIVE double-blind, randomized study.
Rainer Düsing, Patrick Brunel, InYoung Baek, Fabio Baschiera

J Hypertens· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren alone or in combination with hydrochlorothiazide in patients with the lower ranges of stage 2 hypertension: The ACQUIRE randomized double-blind study.
Henry R Black, Andreas Kribben, Fernando Aguirre Palacios, Mahendra Bijarnia, Annik K Laflamme, Fabio Baschiera

J Clin Hypertens (Greenwich)· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
Matteo Fornai, Rocchina Colucci, Luca Antonioli, Fabio Baschiera, Narcisa Ghisu

Eur J Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis.
Corrado Blandizzi, Matteo Fornai, Rocchina Colucci, Fabio Baschiera, Giovanni Barbara

Br J Pharmacol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved tonsillar disposition of azithromycin following a 3-day oral treatment with 20 mg kg(-1) in paediatric patients.
Fabio Baschiera, Matteo Fornai, Gloria Lazzeri, Corrado Blandizzi, Paolo Bruschini

Pharmacol Res· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients.
Corrado Blandizzi, Tecla Malizia, Giovanna Batoni, Emilia Ghelardi, Fabio Baschiera

Antimicrob Agents Chemother· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis